Pacira BioSciences, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before March 14, 2025 to Discuss Your Rights - PCRX — Neutral
PCRX PRNewsWire — February 14, 2025NEW YORK , Feb. 14, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Pacira BioSciences, Inc. ("Pacira" or the "Company") (NASDAQ: PCRX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Pacira investors who were adversely affected by alleged securities fraud between August 2, 2023 and August 8, 2024.
Levi & Korsinsky Reminds Grocery Outlet Holding Corp. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 31, 2025 - GO — Neutral
GO PRNewsWire — February 14, 2025NEW YORK , Feb. 14, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Grocery Outlet Holding Corp. ("Grocery Outlet" or the "Company") (NASDAQ: GO) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Grocery Outlet investors who were adversely affected by alleged securities fraud between November 7, 2023 and May 7, 2024.
Levi & Korsinsky Notifies Shareholders of Block, Inc.(XYZ) of a Class Action Lawsuit and an Upcoming Deadline — Neutral
XYZ PRNewsWire — February 14, 2025NEW YORK , Feb. 14, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Block, Inc. ("Block" or the "Company") (NYSE: XYZ) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Block investors who were adversely affected by alleged securities fraud between February 26, 2020 and April 30, 2024.
Levi & Korsinsky Reminds Crocs, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 24, 2025 - CROX — Neutral
CROX PRNewsWire — February 14, 2025NEW YORK , Feb. 14, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Crocs, Inc. ("Crocs" or the "Company") (NASDAQ: CROX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Crocs investors who were adversely affected by alleged securities fraud between November 3, 2022 and October 28, 2024.
Class Action Filed Against Cardlytics, Inc. (CDLX) Seeking Recovery for Investors - Contact Levi & Korsinsky — Neutral
CDLX PRNewsWire — February 14, 2025NEW YORK , Feb. 14, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ: CDLX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Cardlytics investors who were adversely affected by alleged securities fraud between March 14, 2024 and August 7, 2024.
Levi & Korsinsky Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIX — Neutral
EPIX PRNewsWire — February 14, 2025NEW YORK , Feb. 14, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in ESSA Pharma Inc. ("ESSA Pharma Inc." or the "Company") (NASDAQ: EPIX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of ESSA Pharma Inc. investors who were adversely affected by alleged securities fraud between December 12, 2023 and October 31, 2024.
Investors in Novo Nordisk A/S Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your Rights - NVO — Neutral
NVO PRNewsWire — February 14, 2025NEW YORK , Feb. 14, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Novo Nordisk A/S ("Novo" or the "Company") (NYSE: NVO) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Novo investors who were adversely affected by alleged securities fraud between November 2, 2022 and December 19, 2024.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 31, 2025 in Integral Ad Science Lawsuit - IAS — Neutral
IAS PRNewsWire — February 14, 2025NEW YORK , Feb. 14, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Integral Ad Science Holding Corp. ("Integral Ad Science" or the "Company") (NASDAQ: IAS) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Integral Ad Science investors who were adversely affected by alleged securities fraud between March 2, 2023 and February 27, 2024.
H&R REIT: How To Buy Apartments At A Double-Digit Discount — Positive
HR HRUFF Seeking Alpha — February 14, 2025H&R REIT is one of Canada's cheapest REITs by price-to-FFO and price-to-NAV basis, but management and turnaround plans are questionable. Founded in 1996, H&R was a diversified REIT but faced challenges as investors preferred specialized REITs and internal issues arose. The 2021 turnaround plan aimed to exit retail and office segments, focusing on residential and industrial properties, but results have been mixed.
Best Value Stocks to Buy for February 14th — Positive
ATGE PAHC Zacks Investment Research — February 14, 2025ATGE and PAHC made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 14, 2025.
Think American Express Is Expensive? This Chart Might Change Your Mind. — Neutral
AXP The Motley Fool — February 14, 2025Glancing at the latest closing price of American Express (AXP 0.36%) might produce a degree of sticker shock. Anyone interested in buying into the storied credit card giant will have to part with more than $310 for a mere single share of the company.
Coinbase Stock Slips After Earnings Bump. Why Crypto's Interesting Again. — Neutral
COIN Barrons — February 14, 2025Donald Trump's return to the White House helped the company to blow past analysts' expectations in the fourth quarter.
The Zacks Analyst Blog JPMorgan Chase, Costco, SAP and Gencor Industries — Neutral
COST GENC JPM SAP Zacks Investment Research — February 14, 2025JPMorgan Chase, Costco, SAP and Gencor Industries are included in this Analyst Blog.
Since President Donald Trump won the 2024 election in early November, U.S. stocks rose in anticipation that he will institute pro-business policies. It hasn't been all smooth sailing on Wall Street, though.
The Zacks Analyst Blog NVIDIA, Palantir Technologies, Alphabet, Microsoft and Intel — Neutral
NVDA PLTR Zacks Investment Research — February 14, 2025NVIDIA, Palantir Technologies, Alphabet, Microsoft and Intel are included in this Analyst Blog.
Advanced Micro Devices: AI Future Needs More Answers (Rating Downgrade) — Neutral
AMD Seeking Alpha — February 14, 2025AMD's Q4 earnings showed strong growth in the Client and Server segments, but AI revenue guidance lacked clarity, leading to increased uncertainty. Client segment revenue grew significantly, with management optimistic about continued market share gains in 2025, despite expected Q1 declines. AI GPU revenue guidance is vague, with potential downward revisions, and competition from NVIDIA raises concerns about AMD's market position.
Warren Buffett's 4th-Quarter Trades Will Be Revealed Today, but Won't Show His Favorite Stock to Buy. Here's Why. — Positive
BRK-A BRK-B The Motley Fool — February 14, 2025The most important day of the first quarter has arrived. Amid a seemingly endless parade of operating results is the Feb. 14 deadline for institutional money managers with at least $100 million in assets under management to file Form 13F with the Securities and Exchange Commission (SEC).
Nvidia Stock Rises. This Is When the Next Big AI Sales Boost Will Come. — Positive
NVDA Barrons — February 14, 2025Nvidia's data-center sales could disappoint in the first half of the year but that's not a reason to sell the stock, according to Mizuho analysts.
Note: Cisco's fiscal year 2024 ended on July 27, 2024.
Apple Q1 Reinforces My Sell Thesis, But With One Massive Caveat — Positive
AAPL Seeking Alpha — February 14, 2025Apple's Q1 2025 report shows underwhelming performance, with only 4% YoY growth, causing investors to question the bullish outlook on the stock. Despite a 10% EPS growth, AAPL's financial engineering, particularly in controlling OpEx, raises doubts about its long-term growth sustainability. Revenue slowdowns are making it harder for the Company to post strong YoY operating margins, revealing weaknesses in its growth strategy.